+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global DNA Vaccine Market Outlook 2022

  • ID: 3803238
  • Report
  • June 2020
  • Region: Global
  • 100 Pages
  • RNCOS E-Services Private Limited

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bharat Biotech
  • GlaxoSmithKline plc.
  • Green Cross Corporation
  • Merck & Co., Inc
  • Novartis International AG
  • Sanofi
  • MORE

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have fewer side-effects associated with them as compared to traditional vaccines. Various vaccines have been introduced in the market based on this technique. Some of the major DNA vaccines include GlaxoSmithKline’s Engerix-B, Twinrix, and Fendrix; Merck’s Gardasil, and Recombivax HB; Protein Sciences Corporation’s Flublok, etc. Currently, the researchers are engaged in developing genetic vaccines for humans. Animal genetic vaccines are already present in the market. These vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen. This DNA is injected into the host body and produces protein for which the body generates an immune response.

This comprehensive report entitled “Global DNA Vaccine Market Outlook 2022” provides an in-depth analysis of the global DNA Vaccines market, presenting readers a profound understanding of the various challenges, drivers, and developments in this industry. The study has publicized that though the numbers of DNA vaccines that target the human clinical segment are relatively fewer in number, however, due to high sales of these vaccines, the DNA vaccine market is forecasted to show phenomenal growth in the coming years.

The report also contains a detailed and in-depth analysis of the segmentation of the DNA vaccines market based on types of DNA vaccines, therapeutic indication, end-users, and geography. Based on the type, the DNA vaccines market is divided into recombinant protein and genetic. Amongst the two segments, the recombinant protein segment accounted for the largest share in the market. This large share is attributed to the presence of a high number of recombinant protein vaccines in the market.

Based on end-user, the report segments the market into humans and animals. The majority of DNA vaccines available in the market are targeted for humans. Moreover, the strong pipeline of human targeted vaccines is likely to aid market growth.

Based on geography, the report further divides the market into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. North America is the largest market for DNA vaccines. The large share of the market is attributed to the government’s initiatives to immunize citizens, coupled with high awareness regarding the benefits of genetic vaccines targeted towards animals. The Asia-Pacific region is slated to witness the highest growth in the forecasted period. This growth is likely to be driven by rising awareness of people regarding the advantages of immunization against HPV and Hepatitis B.

The report also includes pipeline analysis based on the type of phase, therapeutic indications, and type of diseases for which the vaccines have been designed, such as infectious and vector-borne diseases and various types of cancers.

Major players in the DNA Vaccines market are also profiled with company overview, financial overview, product portfolios, recent developments, and strengths and weaknesses. The last section of the report discusses the recommendations which could help the DNA vaccine market grow at a faster pace. Conclusively, the research will prove to be a useful resource for all debut makers in the DNA vaccine industry and potential investors.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bharat Biotech
  • GlaxoSmithKline plc.
  • Green Cross Corporation
  • Merck & Co., Inc
  • Novartis International AG
  • Sanofi
  • MORE

1. Analyst View

2. Research Methodology

3. DNA Vaccine - An Introduction

4. Drivers & Challenges
4.1 Drivers
4.1.1 Increasing Investment
4.1.2 Advantages of DNA Vaccines over Traditional Vaccines
4.1.3 Dramatic Increase in Chronic Disorders
4.1.4 Strong DNA Vaccine Pipeline
4.1.5 Technological Advancements
4.2 Challenges
4.2.1 Uncertainty in the Regulatory System
4.2.2 Lack of Awareness in Developing Countries
4.2.3 Development Limited to Plasmid Vectors

5. DNA Vaccine Market Overview

6. DNA Vaccines Market by Geography
6.1 North America
6.2 Europe
6.3 Asia Pacific

7. DNA Vaccine Market by Type
7.1 Recombinant Protein Vaccines
7.1.1 By Geography (North America, Europe, Asia Pacific)
7.2 Genetic Vaccines
7.2.1 By Geography (North America, Europe, Asia-Pacific)

8. DNA Vaccines Market by End User
8.1 Human
8.2 Animal

9. DNA Vaccines Market by Therapeutic Indication
9.1 Infectious & Vector-Borne Diseases
9.2 Cancer

10. Pipeline Analysis

11. Trends
11.1 Increasing Focus on Genetic Vaccine Development
11.2 Expanding Applications Increasing Popularity of DNA Vaccines
11.3 Partnerships Enhancing Genetic Vaccines Development

12. Company Profiles
12.1 Novartis International AG
12.2 Merck & Co., Inc
12.3 GlaxoSmithKline plc.
12.4 Sanofi
12.5 Zoetis
12.6 Green Cross Corporation
12.7 Inovio Pharmaceuticals, Inc.
12.8 Bharat Biotech
12.9 Indian Immunologicals Ltd.
12.10 Serum Institute of India Pvt. Ltd

13. Recommendations

List of Tables
Table 10-1: Global - DNA Vaccines Pipeline
Table 12-1: Novartis International AG - Product Portfolio
Table 12-2: Novartis International AG - Pipeline Analysis
Table 12-3: Novartis - Key Financials (Million US$), 2017-2019
Table 12-4: Merck & Co. Inc - Product Portfolio
Table 12-5: Merck & Co. Inc - Key Financials (Million US$), 2017-2019
Table 12-6: GlaxoSmithKline - Product Portfolio
Table 12-7: GlaxoSmithKline - Key Financials (Million US$), 2017-2019
Table 12-8: Sanofi - Product Portfolio
Table 12-9: Sanofi - Pipeline Analysis
Table 12-10: Sanofi - Key Financials (Million US$), 2017-2019
Table 12-11: Zoetis - Product Portfolio
Table 12-12: Zoetis - Key Financials (Million US$), 2017-2019
Table 12-13: Green Cross Corporation - Product Portfolio
Table 12-14: Green Cross Corporation - Key Financials (Million US$), 2018 & 2019
Table 12-15: Inovio Pharmaceuticals - Key Financials (Million US$), 2015-2017
Table 12-16: Inovio Pharmaceuticals - Pipeline Analysis
Table 12-17: Bharat Biotech - Product Portfolio
Table 12-18: Indian Immunologicals Ltd. - Product Portfolio
Table 12-19: Serum Institute of India Pvt. Ltd - Product Portfolio
Table 12-20: Serum Institute of India Ltd. - Pipeline Analysis

List of Figures
Figure 5-1: Share of DNA Vaccines in Global Vaccine Market (%), 2016
Figure 5-2: Share of DNA Vaccines in Global Vaccine Market (%), 2022
Figure 5-3: Global - DNA Vaccine Market (Billion US$), 2016-2022
Figure 6-1: Global - DNA Vaccine Market by Geography (%), 2016
Figure 6-2: Global - DNA Vaccine Market by Geography (%), 2022
Figure 6-3: North America - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 6-4: Europe - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 6-5: Asia Pacific - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 7-1: Global - DNA Vaccine Market by Type (%), 2016
Figure 7-2: Global - DNA Vaccine Market by Type (%), 2022
Figure 7-3: Global - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-4: Global - Recombinant Protein Vaccines Market by Geography (%), 2016
Figure 7-5: Global - Recombinant Protein Vaccines Market by Geography (%), 2022
Figure 7-6: North America - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-7: Europe - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-8: Asia Pacific - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-9: Global - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-10: Global - Genetic Vaccines Market by Geography (%), 2016
Figure 7-11: Global - Genetic Vaccines Market by Geography (%), 2022
Figure 7-12: North America - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-13: Europe - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-14: Asia Pacific - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 8-1: Global - DNA Vaccine Market by End User (%), 2016
Figure 8-2: Global - DNA Vaccine Market by End User (%), 2022
Figure 8-3: Global - Human DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 8-4: Global - Animal DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 9-1: Global - DNA Vaccine Market by Therapeutic Segment (%), 2016
Figure 9-2: Global - DNA Vaccine Market by Therapeutic Segment (%), 2022
Figure 9-3: Global - DNA Vaccine Market for Infectious & Vector-Borne Diseases (Billion US$), 2016 & 2022
Figure 9-4: Global - DNA Vaccine Market for Cancer (Billion US$), 2016 & 2022
Figure 10-1: Global - DNA Vaccine Pipeline Analysis by Phase (%), 2016
Figure 10-2: Global - DNA Vaccine Pipeline by Therapeutic Indication (%), 2016
Figure 10-3: Global - DNA Vaccine Pipeline by Vaccine Type (%), 2016
Figure 10-4: Global - DNA Vaccine Pipeline by Application (%), 2016
Figure 12-1: Novartis - Break-up of Revenue by Business Segment (%), 2019
Figure 12-2: Novartis - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-3: Merck & Co. Inc - Break-up of Revenue by Business Segment (%), 2019
Figure 12-4: Merck & Co. Inc - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-5: GlaxoSmithKline - Break-up of Revenue by Business Segment (%), 2019
Figure 12-6: GlaxoSmithKline - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-7: Sanofi - Break-up of Revenue by Business Segment (%), 2019
Figure 12-8: Sanofi - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-9: Zoetis - Break-up of Revenue by Business Segment (%), 2019
Figure 12-10: Zoetis - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-11: Green Cross Corporation - Break-up of Revenue by Business Segment (%), 2019

Note: Product cover images may vary from those shown

Loading
LOADING...

  • Bharat Biotech
  • GlaxoSmithKline plc.
  • Green Cross Corporation
  • Indian Immunologicals Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Merck & Co., Inc
  • Novartis International AG
  • Sanofi
  • Serum Institute of India Pvt. Ltd
  • Zoetis
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll